Back to Search
Start Over
Supplementary Table 2 from Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for In vitro and In vivo Activity
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Table 2 from Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for In vitro and In vivo Activity
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....4c8982f18c50568a562301760f706250